A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT01334918

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Phase 2
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01334918
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01334918. Randomized; no masking; primary purpose diagnostic. Start 2011-04-26 (actual); primary completion 2012-07-02 (actual). Results posted on 2013-09-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
Intervention (Drug)
regadenoson
Intervention (Radiation)
technetium Tc99m sestamibi /technetium Tc99m tetrafosmin
Intervention (Radiation)
Contrast
Intervention (Procedure)
Single Photon Emission Computed Tomography
Intervention (Procedure)
Multidetector Computed Tomography
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01334918
Content hash
7fdf004e46ac9f62805d6bba6e14f4bb685e8580aaa220da330c0f4bb207f0eb